Molecular diagnoses of century-old childhood tumours reveals cancer causing mutations

24 May 2017, 2:29 p.m.

Archived tumour samples

A collection of 100-year old tumour samples held at Great Ormond Street Hospital (GOSH) has helped pinpoint the genetic mutations that cause some of the rarest childhood cancers.

NIHR Great Ormond Street BRC-theme lead Professor Neil Sebire worked with colleagues at the Wellcome Trust Sanger Institute to sequence DNA from tumour samples that had been preserved in blocks of paraffin wax since the 1920s. The team then cross-referenced the samples with archived patient case books which contain information about the patient’s symptoms, condition and diagnosis. Together this information enabled researchers to identify several cancer causing mutations. In one case of the blood vessel cancer (cellular capillary haemangioma) researchers found a mutation in the ASXL1 gene which had not previously been seen in solid tumours.

This proof of principle study shows that it is possible to obtain genetic information from preserved tissue. It also demonstrates the potential of this approach in understanding the genetic basis of rare childhood cancers where the very low incidences mean contemporary tissue samples are scarce

The research was published in a letter to Lancet Oncology  and featured on Radio 4's Inside Science, The Guardian and Nature News.

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.

New consortium aims to help improve care for arthritis patients

A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly

Update for patients and families on industrial action - December 2025

As you may be aware, some of our Resident Doctors will be taking part in planned industrial action from 7am on Wednesday 17 December to 7am on Monday 22 December.

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer